KDM5A and lung adenocarcinoma: HDAC inhibitors can also restore drug sensitivity in resistant lung adenocarcinoma PC9 cells, and removal of class I/II HDACs or KDM5A from HeLa and MCF-7 cells can enhance radiosensitivity45,46.